Managing Partner Jeny Maier Named to Global Competition Review’s Women in Antitrust
May 21, 2025
Axinn managing partner Jeny Maier has been named in the latest edition of Global Competition Review's prestigious "Women in Antitrust."
This year’s list includes outstanding women from 88 firms, consultancies, companies, and organizations across 31 jurisdictions—each recognized for their exceptional contributions to antitrust law and their positive influence on both the market and their colleagues.
Jeny Maier is Axinn’s managing partner and a trusted advisor for Fortune 500 companies navigating the complexities of antitrust law in high-profile, multibillion-dollar deals. With two decades of experience, Jeny stands out for her strategic approach and profound knowledge, earning recognition from Chambers USA and The Legal 500 U.S. as a leading figure in antitrust and competition law.
Click here to read Jeny's profile.
About Axinn
Incisive. Inclusive. Invested. Inquisitive. We’re Axinn. Focusing on antitrust, intellectual property, and litigation, we make it our mission to understand your business, so we can anticipate every move. Acting with precision and conviction, we protect and accelerate your business growth, always thinking ahead.
To subscribe to our publications, click here.
Featured Insights
Featured Insights
CCWC 22nd Annual Career Strategies Conference
Sponsorship
Fordham Competition Law Institute's 53rd Annual Conference on International Antitrust Law and Policy, and Antitrust Economics Workshop
Sponsorship
Antitrust
Women, Influence, & Power in Law Conference 2026
Sponsorship
Antitrust
IP Litigation North America Summit 2026
Sponsorship
Intellectual Property
HNBA/VIA Annual Convention 2026
Sponsorship
Antitrust
30th Annual IBA Competition Conference
Speaking Engagement
Antitrust
ABA 2026 Antitrust Global Seminar Series
Speaking Engagement
Antitrust
Axinn Attorneys Earn Top Honors in Best Lawyers 2027
News
Antitrust
DOJ's Antitrust Division Remains Interested in Your Private Litigation
Byline Articles
Antitrust
Axinn Advises Thermo Fisher Scientific on Completed $1.075 Billion Sale of Microbiology Business to Astorg
Deals & Cases
Antitrust
